Carol J. Wikstrand
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Radiopharmaceutical Chemistry and Applications, Neuroblastoma Research and Treatments, Glioma Diagnosis and Treatment
Most-Cited Works
- → Phase II Trial of Gefitinib in Recurrent Glioblastoma(2003)731 cited
- → Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting(2006)489 cited
- → Heterogeneity of Genotypic and Phenotypic Characteristics of Fifteen Permanent Cell Lines Derived from Human Gliomas(1981)484 cited
- Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.(1995)
- Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.(1983)
- Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII.(1997)
- → EGF mutant receptor vIII as a molecular target in cancer therapy.(2001)325 cited
- Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene.(1995)
- → Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition(2005)244 cited
- Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors.(2003)